What will big changes in Europe’s pharmacovigilance legislation landscape mean for the way pharma operates now and in the future? This question is one that seems to be constantly queried within the pharma industry recently, as professionals debate what significant challenges their organisations will face and how these can be overcome. We recently asked Ralph [...]
There have so far only been three cancer vaccines approved by the FDA, and many others are now nearing the end of their clinical trials. Two of these were vaccines for HPV, which is responsible for 70% of cervical cancer. The most recent, and most exciting is the approval of Provenge last year, which is [...]
CBI, a subsidiary of Advanstar Communications, is pleased to announce the agenda for CBI’s Forum on Sponsor/CRO System and Business Process Integration taking place November 15-16, 2012 at the Hilton in East Brunswick, New Jersey. This meeting provides a platform to determine the industry solutions for improved global clinical data access. Join industry colleagues for [...]
Cells grown on different types of scaffolds vary in their ability to help repair damaged blood vessels Tissue implants made of cells grown on a sponge-like scaffold have been shown in clinical trials to help heal arteries scarred by atherosclerosis and other vascular diseases. However, it has been unclear why some implants work better than [...]
Among pregnant women who did not develop gestational diabetes, overweight women were 65 percent more likely, and obese women 163 percent more likely, to have overly large babies than their healthy weight counterparts. In this study, an overly large infant was identified based on having a birth weight over the 90th percentile for their gestational [...]
